Celldex Therapeutics, Inc. (CLDX)

26.70 -0.37 (-1.37%) USD  |  NASDAQ  |  Dec 16, 16:00
26.27 -0.43 (-1.61%) After-Hours: 19:06
More

Celldex Therapeutics Cash and Short Term Investments (Quarterly): 577.22M for Sept. 30, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CLDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Atossa Therapeutics, Inc. 51.96M
Abeona Therapeutics, Inc. 207.46M
Phibro Animal Health Corp. 85.27M
Kiora Pharmaceuticals, Inc. 19.38M
Intellia Therapeutics, Inc. 511.04M